C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT

e-pub ahead of print date: 1 March 2020

Published date: March 2020

Additional Information: Funding Information: Declared competing interests of authors: Christopher C Butler reports that Afinion C-reactive protein devices and associated training given to participating general practices were provided by Alere Inc. (now Abbott Diagnostics, IL, USA) at no cost to the study. He has received fees for participating in a Roche Molecular Systems Advisory Board meeting on 4 and 5 February 2016 about point-of-care testing; held an investigator-initiated grant from Roche Molecular Diagnostics (Roche Molecular Systems Inc., CA, USA) to evaluate the analytic performance of the cobas® Liat® point-of-care device for detecting influenza using samples from a separately funded study; and is part of a publicly funded research consortia that includes industrial partners. He was a member of the Medical Research Council–National Institute for Health Research (MRC–NIHR) Efficacy and Mechanism Evaluation Board (2012–16). He has been a NIHR Senior Investigator since 2016. Kerenza Hood was a member of the Health Technology Assessment (HTA) programme Funding Boards Policy Group (formerly Clinical Studies Group) (2016 to present), the HTA General Board (2016 to present) and the NIHR Clinical Trials Unit Standing Advisory Committee (2014 to 2019). Gurudutt Naik reports non-financial support from Alere Inc. Carl Llor reports grants from the European Commission (Seventh Framework Programme and Horizon 2020), the Catalan Society of Family Medicine, Abbott Diagnostics and Instituto de Salud Carlos III (Spanish Ministry of Health) outside the submitted work. Rhiannon Phillips reports that her current post is a fellowship funded by Health and Care Research Wales as part of the Primary and Emergency Care Research Centre Wales research centre grant. Funding Information: The research reported in this issue of the journal was funded by the HTA programme as project number 12/33/12. The contractual start date was in July 2014. The draft report began editorial review in March 2018 and was accepted for publication in August 2018. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report. Funding Information: This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care. Funding Information: Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 15. See the NIHR Journals Library website for further project information. Funding Information: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 15. See the NIHR Journals Library website for further project information. Publisher Copyright: © Queen’s Printer and Controller of HMSO 2020.

Local EPrints ID: 441350

URI: http://eprints.soton.ac.uk/id/eprint/441350

DOI: doi:10.3310/hta24150

ISSN: 1366-5278

PURE UUID: ec266526-e9da-4b0d-8e8d-542028270fb0

ORCID for Nick A Francis: orcid.org/0000-0001-8939-7312

Date deposited: 10 Jun 2020 16:31

Last modified: 17 Mar 2024 03:58